Annual ROE:
-211.71%-18.48%(-9.56%)Summary
- As of today, RARE annual return on equity is -211.71%, with the most recent change of -18.48% (-9.56%) on December 31, 2024.
- During the last 3 years, RARE annual ROE has fallen by -167.99% (-384.24%).
- RARE annual ROE is now -925.73% below its all-time high of -20.64%, reached on December 31, 2020.
Performance
RARE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-196.21%+8.85%(+4.32%)Summary
- As of today, RARE quarterly return on equity is -196.21%, with the most recent change of +8.85% (+4.32%) on June 30, 2025.
- Over the past year, RARE quarterly ROE has increased by +93.79% (+32.34%).
- RARE quarterly ROE is now -1266.36% below its all-time high of -14.36%, reached on December 31, 2012.
Performance
RARE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RARE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -9.6% | +32.3% |
| 3Y3 Years | -384.2% | -233.8% |
| 5Y5 Years | -231.9% | -357.8% |
RARE ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -384.2% | at low | -119.9% | +49.0% |
| 5Y | 5-Year | -925.7% | at low | -705.5% | +49.0% |
| All-Time | All-Time | -925.7% | at low | -1266.4% | +49.0% |
RARE ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -196.21%(+4.3%) |
| Mar 2025 | - | -205.06%(-5.5%) |
| Dec 2024 | -211.71%(-9.6%) | -194.36%(+14.2%) |
| Sep 2024 | - | -226.56%(+21.9%) |
| Jun 2024 | - | -290.00%(+24.6%) |
| Mar 2024 | - | -384.83%(-28.0%) |
| Dec 2023 | -193.23%(-74.1%) | -300.57%(-13.8%) |
| Sep 2023 | - | -264.14%(-35.5%) |
| Jun 2023 | - | -194.91%(-36.4%) |
| Mar 2023 | - | -142.88%(-30.0%) |
| Dec 2022 | -110.96%(-153.8%) | -109.90%(-23.2%) |
| Sep 2022 | - | -89.23%(-51.8%) |
| Jun 2022 | - | -58.79%(-17.0%) |
| Mar 2022 | - | -50.24%(-11.5%) |
| Dec 2021 | -43.72%(-111.8%) | -45.07%(-21.2%) |
| Sep 2021 | - | -37.19%(+3.9%) |
| Jun 2021 | - | -38.68%(-58.8%) |
| Mar 2021 | - | -24.36%(+1.3%) |
| Dec 2020 | -20.64%(+67.6%) | -24.68%(+35.5%) |
| Sep 2020 | - | -38.24%(+10.8%) |
| Jun 2020 | - | -42.86%(+25.4%) |
| Mar 2020 | - | -57.48%(-5.5%) |
| Dec 2019 | -63.79%(-60.2%) | -54.47%(-1.7%) |
| Sep 2019 | - | -53.54%(-6.3%) |
| Jun 2019 | - | -50.39%(-11.3%) |
| Mar 2019 | - | -45.26%(-41.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -39.83%(+43.5%) | -32.05%(+5.0%) |
| Sep 2018 | - | -33.73%(+4.1%) |
| Jun 2018 | - | -35.19%(+17.4%) |
| Mar 2018 | - | -42.58%(+39.7%) |
| Dec 2017 | -70.48%(-44.0%) | -70.56%(-7.1%) |
| Sep 2017 | - | -65.89%(-8.9%) |
| Jun 2017 | - | -60.52%(-8.9%) |
| Mar 2017 | - | -55.57%(-8.2%) |
| Dec 2016 | -48.93%(-20.3%) | -51.34%(-11.6%) |
| Sep 2016 | - | -46.01%(-6.4%) |
| Jun 2016 | - | -43.23%(-10.3%) |
| Mar 2016 | - | -39.19%(-5.1%) |
| Dec 2015 | -40.67%(+20.1%) | -37.28%(-12.8%) |
| Sep 2015 | - | -33.04%(+5.5%) |
| Jun 2015 | - | -34.96%(-8.1%) |
| Mar 2015 | - | -32.35%(+18.5%) |
| Dec 2014 | -50.88%(+2.5%) | -39.70%(+8.1%) |
| Sep 2014 | - | -43.20%(+15.6%) |
| Jun 2014 | - | -51.18%(-18.1%) |
| Mar 2014 | - | -43.35%(+6.3%) |
| Dec 2013 | -52.17%(-26.7%) | -46.26%(-26.8%) |
| Sep 2013 | - | -36.49%(-48.8%) |
| Jun 2013 | - | -24.53%(-9.8%) |
| Mar 2013 | - | -22.35%(-55.6%) |
| Dec 2012 | -41.19%(+41.3%) | -14.36% |
| Dec 2011 | -70.15% | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual return on equity?
- What is the all-time high annual ROE for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual ROE year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly ROE year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual return on equity?
The current annual ROE of RARE is -211.71%
What is the all-time high annual ROE for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual return on equity is -20.64%
What is Ultragenyx Pharmaceutical Inc. annual ROE year-on-year change?
Over the past year, RARE annual return on equity has changed by -18.48% (-9.56%)
What is Ultragenyx Pharmaceutical Inc. quarterly return on equity?
The current quarterly ROE of RARE is -196.21%
What is the all-time high quarterly ROE for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly return on equity is -14.36%
What is Ultragenyx Pharmaceutical Inc. quarterly ROE year-on-year change?
Over the past year, RARE quarterly return on equity has changed by +93.79% (+32.34%)